DE SIMONE, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 12.216
NA - Nord America 11.119
EU - Europa 10.564
SA - Sud America 1.813
AF - Africa 298
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 14
Totale 36.053
Nazione #
US - Stati Uniti d'America 10.591
SG - Singapore 7.267
RU - Federazione Russa 5.054
CN - Cina 2.146
BR - Brasile 1.464
HK - Hong Kong 1.284
IT - Italia 955
VN - Vietnam 848
UA - Ucraina 806
DE - Germania 775
SE - Svezia 723
FI - Finlandia 675
IE - Irlanda 478
NL - Olanda 415
CA - Canada 351
GB - Regno Unito 295
IN - India 149
AR - Argentina 133
ZA - Sudafrica 104
MX - Messico 101
FR - Francia 87
AT - Austria 67
EC - Ecuador 65
BD - Bangladesh 63
ID - Indonesia 63
CI - Costa d'Avorio 60
PL - Polonia 59
TR - Turchia 54
JP - Giappone 46
IQ - Iraq 40
VE - Venezuela 33
CO - Colombia 32
ES - Italia 27
KR - Corea 27
UZ - Uzbekistan 25
MA - Marocco 24
CL - Cile 23
PY - Paraguay 22
BE - Belgio 20
LT - Lituania 20
PK - Pakistan 20
KE - Kenya 17
SA - Arabia Saudita 17
IR - Iran 16
DO - Repubblica Dominicana 15
EG - Egitto 15
IL - Israele 15
PE - Perù 14
AE - Emirati Arabi Uniti 13
RO - Romania 13
UY - Uruguay 13
AU - Australia 12
BG - Bulgaria 12
BO - Bolivia 12
CH - Svizzera 11
JO - Giordania 11
AZ - Azerbaigian 10
CZ - Repubblica Ceca 10
TN - Tunisia 9
KH - Cambogia 8
NP - Nepal 8
JM - Giamaica 7
KZ - Kazakistan 7
TJ - Tagikistan 7
CR - Costa Rica 6
EU - Europa 6
GE - Georgia 6
HR - Croazia 6
KG - Kirghizistan 6
NZ - Nuova Zelanda 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
AD - Andorra 5
BA - Bosnia-Erzegovina 5
DK - Danimarca 5
ET - Etiopia 5
HN - Honduras 5
LA - Repubblica Popolare Democratica del Laos 5
ME - Montenegro 5
MR - Mauritania 5
NC - Nuova Caledonia 5
PA - Panama 5
PS - Palestinian Territory 5
AO - Angola 4
BB - Barbados 4
BH - Bahrain 4
CW - ???statistics.table.value.countryCode.CW??? 4
DZ - Algeria 4
GA - Gabon 4
GT - Guatemala 4
KW - Kuwait 4
ML - Mali 4
MY - Malesia 4
NG - Nigeria 4
NI - Nicaragua 4
PH - Filippine 4
PR - Porto Rico 4
PT - Portogallo 4
RS - Serbia 4
SN - Senegal 4
Totale 35.934
Città #
Singapore 3.181
Chandler 1.361
Hong Kong 1.281
Moscow 1.197
Jacksonville 891
Millbury 624
Beijing 612
Ashburn 574
Santa Clara 528
Princeton 517
Amsterdam 389
Nanjing 357
Los Angeles 329
Boston 300
Ottawa 277
Ho Chi Minh City 256
Buffalo 242
Wilmington 234
Munich 222
Naples 221
Dallas 157
Napoli 149
Woodbridge 149
Ann Arbor 148
Hefei 148
Hanoi 139
Redondo Beach 136
Dong Ket 132
Nanchang 129
Houston 128
The Dalles 128
São Paulo 124
Seattle 114
Boardman 104
New York 102
Kronberg 93
Helsinki 88
Des Moines 87
Hebei 84
Turku 82
Shenyang 75
Mexico City 62
Jiaxing 60
Norwalk 59
Falls Church 54
Pune 54
Changsha 51
Tianjin 51
Warsaw 51
Nuremberg 48
Rio de Janeiro 47
Falkenstein 45
Tokyo 44
Haiphong 43
Rome 43
Brooklyn 42
Chicago 39
Dublin 36
Frankfurt am Main 36
Johannesburg 34
Atlanta 33
Belo Horizonte 33
London 33
Orem 32
Stockholm 32
Vienna 32
Da Nang 31
Chennai 30
Hangzhou 30
Lawrence 30
Brasília 28
Kunming 28
Montreal 27
Curitiba 26
San Francisco 26
Washington 26
Orange 24
Phoenix 24
Redwood City 24
Toronto 24
Manchester 23
Denver 22
Guarulhos 22
Guayaquil 22
Hải Dương 22
Milan 22
Tashkent 21
Poplar 20
Ankara 19
Guangzhou 19
Seoul 18
Campinas 17
Shanghai 17
Ninh Bình 16
São Bernardo do Campo 16
Biên Hòa 15
Dearborn 15
Quito 15
Dhaka 14
Goiânia 14
Totale 17.930
Nome #
A case of phenotypic Anderson-Fabry disease in a female patient 156
Type of myocardial infarction presentation in patients with chronic kidney disease. 153
[Hemodynamic adaptation in severe obesity with or without arterial hypertension] 152
Body Build and Risk of Cardiovascular Events in Hypertension and Left Ventricular Hypertrophy. The LIFE Study. 150
2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility 141
Is High Pulse Pressure a Marker of Preclinical Cardiovascular Disease? 138
Higher pulse pressure and risk for cardiovascular events in patients with essential hypertension: The Campania Salute Network 131
2018 ESC/ESH Guidelines for the management of arterial hypertension 128
Different Normalizations for Body Size and Population Attributable Risk of Left Ventricular Hypertrophy: the MAVI Study. 125
Weight loss facilitates reduction of left ventricular mass in obese hypertensive patients: The Campania Salute Network 124
Utility of Thiazide Diuretics in Combination Therapy of Hypertension 124
Atrial Dilatation Development in Hypertensive Treated Patients: The Campania-Salute Network 123
Estimate of White-coat Effect and Arterial Stiffness 119
Effects of Nutraceuticals on Prevalence of Metabolic Syndrome and on Calculated Framingham Risk Score in Subjects with Dyslipidemia 119
Improved cardiovascular diagnostic accuracy by pocket size imaging device in non cardiologic outpatients. The NaUSiCa (Naples Ultrasound Sthetoscope in Cardiology) Study. 118
Achievement of target SBP without attention to decrease in DBP can increase cardiovascular morbidity in treated arterial hypertension: the Campania Salute Network registry 118
Depressed myocardial energetic efficiency is associated with increased cardiovascular risk in hypertensive left ventricular hypertrophy 118
Left Ventricular Diastolic Dysfunction in Type I Gaucher Disease: An Echo Doppler Study. 117
Effects of Sibutramine-induced Weight Loss on Cardiovascular System in Obese Subjects 117
Association of suboptimal blood pressure control with body size and metabolic abnormalities. 117
Should Thiazide Diuretics be Given as First Line Antihypertensive Therapy or in Addition to Other Medications? 116
Coronary Flow Reserve in Patients with Hypercholesterolemia and without Coronary Heart Disease. 115
Prognostic impact of increased pulse pressure/stroke index in a registry of hypertensive patients: the Campania Salute Network 115
Effect of diabetes and metabolic syndrome on myocardial mechano-energetic efficiency in hypertensive patients. The Campania Salute Network 115
Statins and Incident Diabetes 114
Left Ventricular Mass Is a Predictor of Follow-Up Uncontrolled Blood Pressure in Hipertensive Patients. 113
Carotid plaque offsets sex-related differences in cardiovascular risk of young hypertensive patients 112
Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities 112
Left Venticular Hypertrophy and Carotid Atherosclerosis as Predictors of New-Onset Diabetes 112
CHA2DS2-VASc score and left atrial volume dilatation synergistically predict incident atrial fibrillation in hypertension: an observational study from the Campania Salute Network registry 112
Nonsymmetric myocardial contribution to supranormal right ventricular function in the athlete's heart: combined assessment by speckle tracking and real time three-dimensional echocardiography. 112
Development of New Atherosclerotic Plaque in Hypertensive Patients: The Campania-Salute Network 112
Target Organ Damage and Target Systolic Blood Pressure in Clinical Practice: The Campania Salute Network 112
Determinants of aortic root dilatation over time in patients with essential hypertension: The Campania Salute Network 112
Evaluation of concentric Left Ventricular Geometry in Humans: Evidence for Age-Related Systematic Underestimation 111
Identification of Phenotype at Risk of Resistant Hypertension 111
Normalization of ascending aorta dimension for body size influences pathophysiologic correlation in hypertensive patients: the Campania Salute Network 110
Increased Left ventricular Mass and Control of Arterial Hypertension in Hypertensive Patients 110
[Nicardipine in the treatment of arterial hypertension: echocardiographic evaluation] 110
Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients 110
Doppler echocardiography for the assessment of left ventricular diastolic function: methodology, clinical and prognostic value 109
OBESITY, HEART FAILURE AND SUDDEN DEATH 109
Pressione arteriosa sistolica, diastolica e differenziale: aspetti fisiopatologici. 109
Prevention and treatment of implanted central venous catheter (CVC) - related sepsis: a report after six years of home parenteral nutrition (HPN). 109
Cardiovascular ultrasound exploration contributes to predict incident atrial fibrillation in arterial hypertension: the Campania Salute Network 109
Validation of Left Atrial Volume Estimation by Left Atrial Diameter from the Parasternal Long-Axis 109
Association of Blood Pressure With Blood Viscosity in American Indians. The Strong Heart Study 108
Management of the patient with left ventricular hypertrophy 107
High-dose recombinant interleukin-2/verapamil combination in advanced cancer. 107
Effect of Cigarette Smoking on Risk Profile of Patients with Optimally Controlled Hypertension. High Blood Press 2011 107
Prevalence and characteristics of true and apparent treatment resistant hypertension in the Campania Salute Network. 107
2D Speckle Strain Immaging Identifies Depressed Left Atrial function in Hypertensive Patients with Diastolic Dysfunction 106
Clinical Predictors of Development of New Lv Hypertrophy in Treated Hypertensive Patients 106
Determinants of decline of renal function in treated hypertensive patients: the Campania Salute Network 105
Initial Left Ventricular Mass Predicts Probability of Uncontrolled Blood Pressure in Arterial Hypertension 104
A challenging diagnosis of dyspnea: A case report of contralateral reexpansion pulmonary edema 104
Carotid Atherosclerosis Predicts Blood Pressure Control in Patients With Hypertension: The Campania Salute Network Registry 104
Does Therapy With Statins Increase Risk Of Diabetes? 103
Classes of Antihypertensive Medications and Blood Pressure Control in Relation to Metabolic Risk Factors 103
Site-dependency of the E/e' ratio in predicting invasive left ventricular filling pressure in patients with suspected or ascertained coronary artery disease. 103
Interstitial syndrome-lung ultrasound B lines: A potential marker for pulmonary metastases? A case series 103
Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. 102
Acute hyperglycemia does not affect the reactivity of coronary microcirculation in humans. 102
Preclinical Systolic Dysfunction in Patients with Stage 3 Chronic Renal Disease. 102
Partial deficiency of adrenal 11-hydroxylase: A possible cause of primary hypertension 102
Left Ventricular Hypertrophy Regression in Hypertensives: a New Hard Challenge 102
Link of Nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy 101
Metabolic risk factors and left ventricular hypertrophy. 101
Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population 101
Atrial Strain by 2d Speckle Tracking Outperforms Atrial Volume in Identifying Hypertensive Patients with Diastolic Dysfunction 100
Prevalence and Prognostic Significance of Wall-Motion Abnormalities in Adults without Clinically Recognized Cardiovascilar Disease 99
Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy. 99
Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? 99
Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated framingham risk score in individuals with dyslipidemia. 99
Regressione del danno d’organo cardiaco con Telmisartan nello studio ONTARGET/TRASCEND. 99
Supernormal contractility in primary hypertension without left ventricular hypertrophy 98
Influence of fat-free mass on detection of appropriateness of left ventricular mass: the HyperGEN Study. 98
Predictors of Lack of Regression of Left Ventricular Hypertrophy in Treated Hypertensive Patients. 98
Arterial stiffness is associated with carotid atherosclerosis in hypertensive patients (the campania salute network). 98
Identification of Phenotype at Risk of Transition from Systo-Diastolic Hypertension to Isolated Systolic Hypertension 98
Statins Therapy and Incidence of Atrial Fibrillation in Hypertensive Patients 98
Association of Myocardial Energetic Efficiency with Circumferential and Longitudinal Left Ventricular Myocardial Function in Subjects with Increased Body Mass Index (the FATCOR Study) 98
Serial echocardiographic assessment of left ventricular mass: how blinded should readers be? 97
Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. 97
CORONARY FLOW RESERVE IN HYPERTENSIVE PATIENTS WITH APPROPRIATE OR INAPPROPRIATE LEFT VENTRICULAR MASS. 97
Correlates of global area strain in native hypertensive patients: a three-dimensional speckle-tracking echocardiography study. 97
Renal artery stenosis in a young female patient with severe hypertension - a case report 97
Risk factors for arterial hypertension in adults with initial optimal bloodpressure: the Strong Heart Study. 96
Statins therapy in atrial fibrillation in hypertensive patients. 96
Atrial Strain by 2D Speckle Tracking Outperforms Atrial Volume in Identifying Hypertensive Patients with Diastolic Dysfunction 96
Haemodynamic Patterns Hypertension by Interaction between Peripheral Resistance and Arterial Stiffness. 96
Left Ventricular Mass in Hypertrophic Cardiomyopathy Assessed by 2D-Echocardiography: Validation with Magnetic Resonance Imaging 96
Body composition and fat distribution influence systemic hemodynamics in the absence of obesity: the HyperGEN Study. 95
Association of inappropriate left ventricular mass with systolic and diastolic disfunction � The HyperGEN Study 95
Increased left ventricular mass in pre-liver transplantation cirrhotic patients. 95
Myocardial texture in hypertrophic cardiomyopathy 95
Prognostic Value of Serial Electrocardiographic Voltage and Repolarization Changes in Essential Hypertension: The HEART Survey Study. 94
Incident Diabetes in Hypertensive Patients with Uncontrolled Blood Pressure 94
Does Additional Echocardiographic Information Improve Prediction of Cardiovascular Event by Left Ventricular Hypertrophy in Arterial Hypertension? 94
Statins Therapy for Primary Prevention and Risk of Incident Diabetes in Hypertensive Patients 94
Totale 10.880
Categoria #
all - tutte 127.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.023


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.306 0 0 0 0 0 374 154 13 253 127 214 171
2021/20222.569 75 20 12 20 10 53 40 108 487 114 372 1.258
2022/20233.153 589 200 59 316 381 357 8 294 456 340 128 25
2023/20241.948 71 296 242 73 106 213 31 243 17 53 422 181
2024/202511.795 722 990 50 152 155 494 1.058 768 1.314 1.206 3.763 1.123
2025/202610.895 2.300 1.319 1.831 1.416 3.392 637 0 0 0 0 0 0
Totale 36.586